Change of Lifestyle by Persons in Risk of Type 2 Diabetes

Sponsor
Sorlandet Hospital HF (Other)
Overall Status
Unknown status
CT.gov ID
NCT00202748
Collaborator
(none)
220
1
36
6.1

Study Details

Study Description

Brief Summary

We know that changing lifestyle can prevent type 2 diabetes. The challenge is how to help people changing their lifestyle. We have people in 2 groups: half of them is meeting in grops of 10 persons (interventiongroup), the other ones are just visiting their doctor (controlgroup).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Increase in activity to control weight
  • Behavioral: Increase in activity to control weight.
Phase 3

Detailed Description

The intervention group are meeting different healt proffesionals (nurse, doctor, eksperts on nutrition,experts on activity and experts on how to change. They have 7 meetings in groups of 10 persons over 3 months. The controlgroup are just meeting their own doctor or the doctor in the hospital 2 times a year.

We tell all that small changes are making big differenses (in weight and the chanse of getting ill). Everyone is told that lack of aktivity is the main reason to obesity. Lack of activity also influense in whar you eat. herefore is activity in the "center".

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Phase 3 Study of Changing of Lifestyle by Persons in Risk of Type 2 Diabetes
Study Start Date :
Mar 1, 2004
Study Completion Date :
Mar 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Weigtreduction []

  2. Increase in maximum oxygen uptake []

  3. Change in foodintake []

  4. Change in self-reported activity []

Secondary Outcome Measures

  1. Quality of life []

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: Diabetes risk score above 9 points.

Exclusion Criteria: Persons with diabetes, serious heart disease, cancer or psychiatric disorder. They have to speak and understand Norwegian language.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sorlandet Hospital Kristiansand Serviceboks 416 Norway 4604

Sponsors and Collaborators

  • Sorlandet Hospital HF

Investigators

  • Study Chair: Frode Gallefoss, Dr.,

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00202748
Other Study ID Numbers:
  • SSHF70201
First Posted:
Sep 20, 2005
Last Update Posted:
Dec 23, 2005
Last Verified:
Dec 1, 2003
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2005